|
US2856414A
(en)
|
|
1958-10-14 |
|
Oxidation of alpha-tocopherol |
|
FR5531E
(fr)
|
1905-03-02 |
1906-05-02 |
Gaston Levy Lajeunesse |
Perfectionnements aux moteurs à explosions
|
|
US2398418A
(en)
|
1943-08-27 |
1946-04-16 |
Louis F Fieser |
Introduction of organic radicals into quinones
|
|
FR1201200A
(fr)
|
1958-08-08 |
1959-12-29 |
Sogespar S A |
Procédé de fabrication de l'alpha tocophéryl-quinone
|
|
US3071512A
(en)
|
1959-01-26 |
1963-01-01 |
Sogespar S A |
New hypotensive pharmaceutical preparation containing alpha-tocopheryl-quinone
|
|
US3406188A
(en)
|
1964-03-27 |
1968-10-15 |
Sun Oil Co |
Preparation of alpha-tocopherylquinone
|
|
FR5531M
(enExample)
|
1966-02-08 |
1967-11-13 |
|
|
|
FR1536576A
(fr)
|
1967-08-29 |
1968-08-16 |
Eastman Kodak Co |
Procédés d'enrichissement et de fractionnement de mélanges à base de tocophérols
|
|
US3849453A
(en)
|
1970-03-17 |
1974-11-19 |
Takeda Chemical Industries Ltd |
Quinone derivatives
|
|
US3705239A
(en)
|
1970-10-16 |
1972-12-05 |
Roy B Gregory |
Pain removing compositions and methods
|
|
UST917001I4
(en)
|
1971-12-02 |
1973-12-04 |
|
Defensive publication |
|
JPS4875564A
(enExample)
|
1972-01-08 |
1973-10-11 |
|
|
|
JPS4988862A
(enExample)
|
1972-12-29 |
1974-08-24 |
|
|
|
JPS5245698B2
(enExample)
|
1973-04-06 |
1977-11-17 |
|
|
|
US3957836A
(en)
|
1973-07-02 |
1976-05-18 |
Takeda Chemical Industries, Ltd. |
Quinone derivatives
|
|
US3909376A
(en)
|
1974-12-04 |
1975-09-30 |
Basf Ag |
Electrolytic manufacture of alkyl-substituted hydroquinones
|
|
JPS52111576A
(en)
|
1976-03-15 |
1977-09-19 |
Teijin Ltd |
Synthesis of 5,7,8-trimethyl-3,4-dehydrotocotrienol
|
|
JPS5938203B2
(ja)
|
1976-04-26 |
1984-09-14 |
エーザイ株式会社 |
補酵素ｑを主成分とする脳循環障害治療剤
|
|
US4153614A
(en)
|
1978-05-12 |
1979-05-08 |
Hoffmann-La Roche Inc. |
Synthesis of (S)-(+)-6-hydroxy-2,5,7,8-tetramethylchroman-2-methanol and intermediates therein
|
|
LU77344A1
(enExample)
|
1977-05-16 |
1979-01-19 |
|
|
|
US4201879A
(en)
|
1977-05-16 |
1980-05-06 |
Hoffmann-La Roche Inc. |
Hydroquinones
|
|
US4201726A
(en)
|
1977-05-17 |
1980-05-06 |
Hoffmann-La Roche Inc. |
Synthesis of Vitamin E
|
|
US4243598A
(en)
|
1977-05-17 |
1981-01-06 |
Hoffmann-La Roche Inc. |
Synthesis of vitamin E
|
|
US4127608A
(en)
|
1977-05-17 |
1978-11-28 |
Hoffmann-La Roche Inc. |
Synthesis of Vitamin E
|
|
US4310465A
(en)
|
1977-05-17 |
1982-01-12 |
Hoffmann-La Roche Inc. |
Synthesis of vitamin E and quinone intermediates
|
|
US4185154A
(en)
|
1977-05-17 |
1980-01-22 |
Hoffmann-La Roche, Inc. |
Synthesis of vitamin E
|
|
JPS5640651A
(en)
|
1979-09-12 |
1981-04-16 |
Takeda Chem Ind Ltd |
Quinone compound and its preparation
|
|
JPS56147746A
(en)
|
1980-04-15 |
1981-11-16 |
Takeda Chem Ind Ltd |
Quinones and their preparation
|
|
JPS567734A
(en)
|
1979-06-28 |
1981-01-27 |
Takeda Chem Ind Ltd |
Preparation of quinone derivative
|
|
JPS567737A
(en)
|
1979-07-02 |
1981-01-27 |
Takeda Chem Ind Ltd |
Physiologically active quinone and its preparation
|
|
JPS5697223A
(en)
|
1979-12-30 |
1981-08-05 |
Takeda Chem Ind Ltd |
Tissue metabolism activator
|
|
JPS56140943U
(enExample)
|
1980-03-19 |
1981-10-24 |
|
|
|
JPH0193554A
(ja)
|
1980-04-07 |
1989-04-12 |
Takeda Chem Ind Ltd |
有機化合物
|
|
JPS56140943A
(en)
|
1980-04-07 |
1981-11-04 |
Takeda Chem Ind Ltd |
Preparation of organic compound
|
|
US4393075A
(en)
|
1980-04-14 |
1983-07-12 |
Takeda Chemical Industries, Ltd. |
Quinone compounds and their use in suppressing the production of SRS-A in mammals
|
|
JPS5750935Y2
(enExample)
|
1980-06-03 |
1982-11-06 |
|
|
|
JPS5750935A
(en)
|
1980-09-12 |
1982-03-25 |
Otsuka Pharmaceut Co Ltd |
1,4-benzoquinone derivative
|
|
JPS57131735A
(en)
|
1981-02-09 |
1982-08-14 |
Takeda Chem Ind Ltd |
Preparation of quinones
|
|
JPS6140236Y2
(enExample)
|
1981-04-03 |
1986-11-17 |
|
|
|
JPS57183782A
(en)
|
1981-04-30 |
1982-11-12 |
Sumitomo Chem Co Ltd |
Preparation of coumarone compound
|
|
JPS5818374A
(ja)
|
1981-07-27 |
1983-02-02 |
Nitsusui Seiyaku Kk |
エイコサペンタエン酸トコフエロ−ルエステル
|
|
JPS5883698A
(ja)
|
1981-11-13 |
1983-05-19 |
Takeda Chem Ind Ltd |
キノン化合物およびその製造法
|
|
JPS5883698U
(ja)
|
1981-11-27 |
1983-06-06 |
石川島播磨重工業株式会社 |
熱交換器
|
|
JPS6028919Y2
(ja)
|
1981-12-28 |
1985-09-02 |
松下電器産業株式会社 |
太陽熱集熱装置
|
|
JPS58193689A
(ja)
|
1982-05-10 |
1983-11-11 |
Shiseido Co Ltd |
テストステロン−５α−レダクタ−ゼ阻害剤
|
|
JPS58193689U
(ja)
|
1982-06-18 |
1983-12-23 |
三菱電機株式会社 |
電子部材実装装置
|
|
DK449983A
(da)
|
1982-10-27 |
1984-04-28 |
Hoffmann La Roche |
Fremgangsmaade til fremstilling af optiske aktive forbindelser
|
|
CH655005A5
(it)
|
1983-02-16 |
1986-03-27 |
Sigma Tau Ind Farmaceuti |
Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare.
|
|
JPS59163316A
(ja)
|
1983-03-08 |
1984-09-14 |
Eisai Co Ltd |
けいれんの治療・予防剤
|
|
JPS6028919A
(ja)
|
1983-07-28 |
1985-02-14 |
Shiseido Co Ltd |
皮膚外用剤
|
|
EP0134198A1
(de)
|
1983-08-10 |
1985-03-13 |
Ciba-Geigy Ag |
Verwendung von Chinonderivaten zum Schützen von Kulturpflanzen vor der phytotoxischen Wirkung von Herbiziden
|
|
JPS60197621A
(ja)
|
1984-03-19 |
1985-10-07 |
Hohnen Oil Co Ltd |
コレステロ−ル低下剤
|
|
US5304658A
(en)
|
1984-08-01 |
1994-04-19 |
Takeda Chemical Industries, Ltd. |
Quinone derivatives, their production and use
|
|
MX9203040A
(es)
|
1984-08-01 |
1992-07-31 |
Takeda Chemical Industries Ltd |
Derivados de quinona y composicion farmaceutica que los contiene.
|
|
JPS6140236A
(ja)
|
1984-08-02 |
1986-02-26 |
Yamanouchi Pharmaceut Co Ltd |
ハイドロキノン誘導体
|
|
US4592867A
(en)
|
1984-10-19 |
1986-06-03 |
Energy Conversion Devices, Inc. |
Synthesis method for reductant precursor
|
|
US4617317A
(en)
|
1984-10-31 |
1986-10-14 |
Bennet Justin D |
Method of treating ulcerative colitis
|
|
EP0183869B1
(en)
|
1984-12-06 |
1991-04-17 |
Kuraray Co., Ltd. |
Chroman compounds and their use
|
|
JPH0511467Y2
(enExample)
|
1985-03-19 |
1993-03-22 |
|
|
|
US5229385A
(en)
|
1986-01-30 |
1993-07-20 |
Takeda Chemical Industries, Ltd. |
Quinone derivatives, their production and use
|
|
US4883658A
(en)
|
1986-04-28 |
1989-11-28 |
Holly Frank J |
Ophthalmic solution for treatment of dry-eye syndrome
|
|
US4804539A
(en)
|
1986-07-28 |
1989-02-14 |
Liposome Technology, Inc. |
Ophthalmic liposomes
|
|
JPH0788376B2
(ja)
|
1986-09-02 |
1995-09-27 |
エーザイ株式会社 |
光学活性α−トコトリエノ−ルの製造方法
|
|
GB8626344D0
(en)
|
1986-11-04 |
1986-12-03 |
Zyma Sa |
Bicyclic compounds
|
|
US5057514A
(en)
|
1987-02-03 |
1991-10-15 |
Suntory Limited |
Compounds effective as cerebral schemia treating agents
|
|
US5278151A
(en)
|
1987-04-02 |
1994-01-11 |
Ocular Research Of Boston, Inc. |
Dry eye treatment solution
|
|
US4914088A
(en)
|
1987-04-02 |
1990-04-03 |
Thomas Glonek |
Dry eye treatment solution and method
|
|
US5288752A
(en)
|
1987-12-22 |
1994-02-22 |
Suntory Limited |
Compound effective as cerebral insufficiency improver
|
|
US5179092A
(en)
|
1987-12-22 |
1993-01-12 |
Suntory Limited |
Compound effective as cerebral insufficiency improver
|
|
DK36389A
(da)
|
1988-02-05 |
1989-08-06 |
Eastman Kodak Co |
Praeparat og fremgangsmaade til at forebygge vaevskader ved reperfusion
|
|
JPH01209445A
(ja)
|
1988-02-17 |
1989-08-23 |
Fuji Photo Film Co Ltd |
放射線感応性材料
|
|
JP2685785B2
(ja)
|
1988-03-11 |
1997-12-03 |
エーザイ株式会社 |
光学活性α−トコトリエノールの製造方法
|
|
AU618791B2
(en)
|
1988-03-16 |
1992-01-09 |
Bioindustry Development Centre |
Production of high concentration tocopherols and tocotrienols from palm oil by-product
|
|
DE3818696C1
(en)
|
1988-06-01 |
1989-03-30 |
Ems-Inventa Ag, Zuerich, Ch |
Process for the preparation of hydroquinone and its alkyl derivatives
|
|
US5075104A
(en)
|
1989-03-31 |
1991-12-24 |
Alcon Laboratories, Inc. |
Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
|
|
JPH08768B2
(ja)
|
1989-08-24 |
1996-01-10 |
武田薬品工業株式会社 |
神経成長因子分泌誘導剤
|
|
FI102273B1
(fi)
|
1989-09-11 |
1998-11-13 |
Eisai Co Ltd |
Kinonijohdannaiset, niiden valmistaminen ja niiden farmakologinen käyttö
|
|
US5157132A
(en)
|
1990-05-18 |
1992-10-20 |
Carotech Associates |
Integrated process for recovery of carotenoids and tocotrienols from oil
|
|
ZA912797B
(en)
|
1990-05-29 |
1992-12-30 |
Boston Ocular Res |
Dry eye treatment process and solution
|
|
ES2084722T3
(es)
|
1990-05-29 |
1996-05-16 |
Boston Ocular Res |
Composicion para tratamiento del ojo seco.
|
|
JP3086284B2
(ja)
|
1991-07-05 |
2000-09-11 |
京セラミタ株式会社 |
電子写真感光体
|
|
ZA927277B
(en)
|
1991-10-02 |
1993-05-19 |
Boston Ocular Res |
Dry eye treatment process and solution.
|
|
CA2124086A1
(en)
|
1991-11-22 |
1993-05-27 |
Ronald H. Lane |
Tocotrienols and tocotrienol-like compounds and methods for their use
|
|
EP0560568A3
(en)
|
1992-03-13 |
1994-06-29 |
Takeda Chemical Industries Ltd |
Hydroquinone derivatives and intermediates for production thereof
|
|
WO1993024650A1
(en)
|
1992-05-28 |
1993-12-09 |
Monash University |
Therapeutic compositions
|
|
CN1093360A
(zh)
|
1992-10-02 |
1994-10-12 |
武田药品工业株式会社 |
2-o-烷基抗坏血酸的锂盐
|
|
EP0629400B1
(en)
|
1993-06-18 |
1999-09-22 |
Takeda Chemical Industries, Ltd. |
Idebenone compositions for treating Alzheimer's disease
|
|
US5600029A
(en)
|
1994-03-09 |
1997-02-04 |
Takeda Chemical Industries, Ltd. |
Process for producing DL-tocopherols and intermediates therefor
|
|
EP0708646A1
(en)
|
1994-05-06 |
1996-05-01 |
Alcon Laboratories, Inc. |
Use of vitamin e tocopheryl derivatives in ophthalmic compositions
|
|
EP0774967A1
(en)
|
1994-08-12 |
1997-05-28 |
Takeda Chemical Industries, Ltd. |
Use of quinone and hydroquinone derivatives for the teatment of cachexia
|
|
US6150402A
(en)
|
1994-08-15 |
2000-11-21 |
Loma Linda University Medical Center |
Natriuretic compounds
|
|
JPH0892151A
(ja)
|
1994-09-29 |
1996-04-09 |
Sagami Chem Res Center |
アリルキノンの製造方法
|
|
US5547827A
(en)
|
1994-12-22 |
1996-08-20 |
Eastman Kodak Company |
Iodochloride emulsions containing quinones having high sensitivity and low fog
|
|
CA2166017A1
(en)
|
1994-12-26 |
1996-06-27 |
Yasuko Ashida |
Pharmaceutical composition for the dermatitis
|
|
CA2207333C
(en)
|
1994-12-28 |
2006-10-17 |
Janssen Pharmaceutica, Naamloze Vennootschap |
Use of nebivolol as an anti-atherogenic
|
|
US20030134028A1
(en)
|
1995-06-01 |
2003-07-17 |
Lipton, Division Of Conopco, Inc. |
Fat based food products
|
|
CA2227985A1
(en)
|
1995-08-21 |
1997-02-27 |
Takeda Chemical Industries, Ltd. |
Quinone compound, its production and use
|
|
US6232060B1
(en)
|
1996-01-19 |
2001-05-15 |
Galileo Laboratories, Inc. |
Assay system for anti-stress agents
|
|
US5801159A
(en)
|
1996-02-23 |
1998-09-01 |
Galileo Laboratories, Inc. |
Method and composition for inhibiting cellular irreversible changes due to stress
|
|
ATE201204T1
(de)
|
1996-03-25 |
2001-06-15 |
Alcon Lab Inc |
Derivate der thiazolidine-4-carbonsäure als cytoprotektive mittel
|
|
EP0915696B1
(en)
|
1996-07-11 |
2002-05-29 |
Takeda Chemical Industries, Ltd. |
ANTI-beta-AMYLOID PROTEIN-INDUCED CYTOTOXICITY COMPOSITION
|
|
FR2753098B1
(fr)
|
1996-09-06 |
1998-11-27 |
Sod Conseils Rech Applic |
Composition pharmaceutique comprenant au moins un inhibiteur de no synthase et au moins un piegeur des formes reactives de l'oxygene
|
|
GB9702310D0
(en)
|
1997-02-05 |
1997-03-26 |
Univ Hertfordshire |
Invention
|
|
GB9722361D0
(en)
|
1997-10-24 |
1997-12-17 |
Pharma Nord Uk Ltd |
Pharmaceutical formulation for treating liver disorders
|
|
EP1037628A4
(en)
|
1997-11-17 |
2002-08-21 |
Lipogenics Inc |
METHOD FOR PREVENTING RESTENOSE USING TOCOTRIENOLE
|
|
US6331532B1
(en)
|
1998-11-25 |
2001-12-18 |
University Of Otago |
Mitochondrially targeted antioxidants
|
|
ES2207931T3
(es)
|
1998-01-29 |
2004-06-01 |
Eastman Chemical Company |
Procedimientos para separar un tocotrienol de una mezcla a base de tocol y composiciones producidas segun dichos procedimientos.
|
|
US5969133A
(en)
|
1998-05-22 |
1999-10-19 |
Shiongi Bioresearch Corp. |
Bioreductive cytotoxic agents
|
|
US6433199B1
(en)
|
1998-05-22 |
2002-08-13 |
Shionogi Bioresearch Corporation |
Quinone derivatives
|
|
US6342516B1
(en)
|
1998-07-31 |
2002-01-29 |
Nippon Soda Co., Ltd. |
Phenylazole compounds, process for producing the same and drugs for hyperlipemia
|
|
US6472378B2
(en)
|
1998-08-31 |
2002-10-29 |
Pro-Neuron, Inc. |
Compositions and methods for treatment of mitochondrial diseases
|
|
IT1304406B1
(it)
|
1998-10-21 |
2001-03-19 |
Danital Italia S R L |
Preparazione per la veicolazione di principi attivi basata su acidigrassi polinsaturi del gruppo omega 3.
|
|
US6187811B1
(en)
|
1998-10-28 |
2001-02-13 |
Lipogenics, Inc. |
Methods for treating benign prostatic hyperplasia using tocotrienols
|
|
US6133322A
(en)
|
1998-10-29 |
2000-10-17 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Quinone derivatives for treating or preventing diseases associated with iron overload
|
|
EP1044687B1
(en)
|
1998-11-06 |
2008-09-03 |
Fuji Chemical Industry Co., Ltd. |
Powders containing tocotrienols and tablets prepared by compression molding the same
|
|
US6048891A
(en)
|
1998-12-17 |
2000-04-11 |
Loma Linda University Medical Center |
Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of natriuretic disease
|
|
JP2000202297A
(ja)
|
1999-01-20 |
2000-07-25 |
Chemiprokasei Kaisha Ltd |
新規な酸化反応用触媒およびそれを用いたｐ―ベンゾキノン類の製造方法
|
|
US7638501B1
(en)
|
1999-02-23 |
2009-12-29 |
The Regents Of The University Of California |
Method of treatment of mitochondrial disorders
|
|
US6761903B2
(en)
|
1999-06-30 |
2004-07-13 |
Lipocine, Inc. |
Clear oil-containing pharmaceutical compositions containing a therapeutic agent
|
|
US6045826A
(en)
|
1999-04-02 |
2000-04-04 |
National Research Council Of Canada |
Water-soluble compositions of bioactive lipophilic compounds
|
|
US6632443B2
(en)
|
2000-02-23 |
2003-10-14 |
National Research Council Of Canada |
Water-soluble compositions of bioactive lipophilic compounds
|
|
DE19916801A1
(de)
|
1999-04-14 |
2000-11-02 |
Bosch Gmbh Robert |
Spritzdüse für eine Scheibenwaschanlage
|
|
WO2000078296A2
(en)
|
1999-06-17 |
2000-12-28 |
Basf Aktiengesellschaft |
Tocotrienol and/or tocotrienol derivatives for the treatment or prophylaxis of glutamate- and/or calcium-induced disorders
|
|
US6395915B1
(en)
|
1999-09-10 |
2002-05-28 |
Technikrom, Inc. |
Method for producing purified tocotrienols and tocopherols using liquid chromatography
|
|
US6528042B1
(en)
|
1999-10-08 |
2003-03-04 |
Galileo Laboratories, Inc. |
Compositions of flavonoids for use as cytoprotectants and methods of making and using them
|
|
US6426362B1
(en)
|
1999-10-08 |
2002-07-30 |
Galileo Laboratories, Inc. |
Formulations of tocopherols and methods of making and using them
|
|
MY127451A
(en)
|
1999-11-04 |
2006-12-29 |
Malaysian Palm Oil Board |
A method of chromatographic isolation for vitamin e isomers
|
|
US8753675B1
(en)
|
2000-01-20 |
2014-06-17 |
Raj K. Chopra |
Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications
|
|
US6740338B1
(en)
|
2000-01-20 |
2004-05-25 |
Raj K. Chopra |
Reduced form of Cenzyme Q in high bioavailability stable oral dosage form
|
|
US6346544B2
(en)
|
2000-03-02 |
2002-02-12 |
Oklahoma Medical Research Foundation |
Desmethyl tocopherols for protecting cardiovascular tissue
|
|
WO2001092215A2
(en)
|
2000-06-02 |
2001-12-06 |
Us Health |
Superoxide-generating diazeniumdiolates, compositions comprising same, and methods for using same
|
|
DE10034233A1
(de)
|
2000-07-14 |
2002-01-24 |
Basf Ag |
Tocotrienolchinon-Cyclisierungsprodukte
|
|
US6545184B1
(en)
|
2000-08-15 |
2003-04-08 |
The Regents Of The University Of California |
Practical, cost-effective synthesis of COQ10
|
|
US20030206972A1
(en)
|
2000-10-13 |
2003-11-06 |
Babish John G. |
Compositions containing carotenoids and tocotrienols and having synergistic antioxidant effect
|
|
DE60117046T2
(de)
|
2000-10-26 |
2006-09-28 |
Fournier Laboratories Ireland Ltd. |
Kombination von fenofibrat und von coenzym q10 für die behandlung der endothelial- missfunktion
|
|
AUPR177300A0
(en)
|
2000-11-29 |
2000-12-21 |
Centre For Molecular Biology And Medicine |
Therapeutic methods
|
|
US20020155170A1
(en)
|
2000-11-30 |
2002-10-24 |
Walsh William John |
Nutrient supplements and methods for treating autism and for preventing the onset of autism
|
|
US20020132845A1
(en)
|
2000-12-15 |
2002-09-19 |
Miller Guy Michael |
Compositions and methods for the prevention and treatment of tissue ischemia
|
|
US7034054B2
(en)
|
2000-12-15 |
2006-04-25 |
Galileo Pharmaceuticals, Inc. |
Methods for the prevention and treatment of cerebral ischemia using non-alpha tocopherols
|
|
US6838104B2
(en)
|
2000-12-20 |
2005-01-04 |
Archer Daniels Midland Company |
Process for the production of tocotrienols
|
|
US20040043013A1
(en)
|
2000-12-28 |
2004-03-04 |
Mccleary Edward Larry |
Metabolic uncoupling therapy
|
|
US6300377B1
(en)
|
2001-02-22 |
2001-10-09 |
Raj K. Chopra |
Coenzyme Q products exhibiting high dissolution qualities
|
|
US6764768B2
(en)
|
2001-02-28 |
2004-07-20 |
Arch Development Corporation |
Controlled release composition
|
|
US6964969B2
(en)
|
2001-04-19 |
2005-11-15 |
Mccleary Edward Larry |
Composition and method for treating impaired or deteriorating neurological function
|
|
US6608196B2
(en)
|
2001-05-03 |
2003-08-19 |
Galileo Pharmaceuticals, Inc. |
Process for solid supported synthesis of pyruvate-derived compounds
|
|
JP2003064017A
(ja)
|
2001-06-12 |
2003-03-05 |
Hokko Chem Ind Co Ltd |
オキシスチレン誘導体の蒸留方法
|
|
US7172905B2
(en)
|
2001-08-07 |
2007-02-06 |
The University Of Chicago |
Polypeptide immobilization
|
|
NZ513547A
(en)
|
2001-08-13 |
2002-09-27 |
Antipodean Biotechnology Ltd |
Synthesis of triphenylphosphonium quinols (e.g. mitoquinol) and/or quinones (e.g. mitoquinone)
|
|
MXPA04001555A
(es)
|
2001-08-21 |
2004-10-27 |
Galileo Pharmaceuticals Inc |
Composiciones enriquecidas con tocoferol y mejoramiento de sintomas inflamatorios.
|
|
CA2357053A1
(en)
|
2001-09-04 |
2003-03-04 |
Unknown |
Effectiveness of a combination of antioxidant substances for the treatment of alzheimer's disease
|
|
JP2003137716A
(ja)
|
2001-10-30 |
2003-05-14 |
Eau De Faveur:Kk |
皮膚の外用剤
|
|
WO2003043570A2
(en)
|
2001-11-15 |
2003-05-30 |
Galileo Laboratories, Inc. |
Formulations and methods for treatment or amelioration of inflammatory conditions
|
|
US6667330B2
(en)
|
2002-01-31 |
2003-12-23 |
Galileo Pharmaceuticals, Inc. |
Furanone derivatives
|
|
US6653346B1
(en)
|
2002-02-07 |
2003-11-25 |
Galileo Pharmaceuticals, Inc. |
Cytoprotective benzofuran derivatives
|
|
US7078541B2
(en)
|
2002-02-07 |
2006-07-18 |
Galileo Pharmaceuticals, Inc. |
Benzofuran derivatives
|
|
US7217133B2
(en)
|
2002-04-04 |
2007-05-15 |
Jeanine Thomas |
Method for treating pervasive development disorder
|
|
AT414082B
(de)
|
2002-05-03 |
2006-09-15 |
Vis Vitalis Lizenz & Handels |
Verfahren zur herstellung von tocotrienol-angereicherten präparationen
|
|
US7327800B2
(en)
|
2002-05-24 |
2008-02-05 |
Vecima Networks Inc. |
System and method for data detection in wireless communication systems
|
|
DE60211875T2
(de)
|
2002-07-01 |
2006-10-26 |
Santhera Pharmaceuticals (Schweiz) Ag |
Screeningverfahren und Verbindungen zur Behandlung von Friedreich ataxia
|
|
US6953331B2
(en)
|
2002-08-30 |
2005-10-11 |
Extreme Components L.P. |
Positioning device with bearing mechanism
|
|
EP1558922B1
(en)
|
2002-10-30 |
2013-02-27 |
Ampere Life Sciences, Inc. |
Identifying therapeutic compounds based on their physical-chemical properties
|
|
JP2007523599A
(ja)
*
|
2003-02-10 |
2007-08-23 |
オートゲン リサーチ ピーティーワイ エルティーディー． |
治療用分子
|
|
US8003094B2
(en)
|
2003-06-25 |
2011-08-23 |
Charles Erwin |
Chemical combination and method for increasing delivery of Coenzyme Q10
|
|
WO2005013911A2
(en)
|
2003-08-08 |
2005-02-17 |
The Ohio State University Research Foundation |
Protective and therapeutic uses for tocotrienols
|
|
CA2536546C
(en)
|
2003-08-22 |
2012-10-02 |
Antipodean Pharmaceuticals, Inc. |
Mitoquinone derivatives used as mitochondrially targeted antioxidants
|
|
US7015243B2
(en)
|
2003-08-28 |
2006-03-21 |
Allergan, Inc. |
Cyclohexyl prostaglandin analogs as EP4-receptor agonists
|
|
WO2005032544A1
(en)
|
2003-09-19 |
2005-04-14 |
Galileo Pharmaceuticals, Inc. |
Treatment of mitochondrial diseases
|
|
WO2005035491A2
(en)
|
2003-10-10 |
2005-04-21 |
Yasoo Health, Inc. |
PROCESS FOR SYNTHESIZING d-TOCOTRIENOLS FROM 2- VINYLCHROMANE COMPOUND
|
|
AU2004316985A1
(en)
|
2004-02-23 |
2005-09-15 |
The Texas A & M University System |
Antioxidant compositions and methods of use thereof
|
|
US7022441B2
(en)
|
2004-02-25 |
2006-04-04 |
Eastman Kodak Company |
Silver-free black-and-white thermographic materials containing a benzoquinone and methods of imaging
|
|
JPWO2005084660A1
(ja)
|
2004-03-05 |
2007-08-09 |
森重 文江 |
ミトコンドリア病予防と対策
|
|
US8182990B2
(en)
|
2004-03-18 |
2012-05-22 |
Rusk Intellectual Reserve Ag |
Method for diagnosing or predicting susceptibility to optic neuropathy
|
|
US7485283B2
(en)
|
2004-04-28 |
2009-02-03 |
Lantheus Medical Imaging |
Contrast agents for myocardial perfusion imaging
|
|
US7972601B2
(en)
|
2004-05-11 |
2011-07-05 |
The Regents Of The University Of California |
Method of promoting delivery of an antioxidant agent to a cell expression neuroligin
|
|
US8116262B2
(en)
|
2004-06-22 |
2012-02-14 |
Rockstar Bidco Lp |
Methods and systems for enabling feedback in wireless communication networks
|
|
DE102004032837A1
(de)
|
2004-07-02 |
2006-02-09 |
Beiersdorf Ag |
Verwendung von Wirkstoffkombinationen aus einem oder mehreren Biochinonen und einem oder mehreren Isoflavonen zur Verbesserung der Hautkonturen
|
|
EP1611879B1
(en)
|
2004-07-02 |
2009-08-12 |
Novagali Pharma SA |
Use of emulsions for intra- and periocular injection
|
|
US7393662B2
(en)
|
2004-09-03 |
2008-07-01 |
Centocor, Inc. |
Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
|
|
KR101270841B1
(ko)
|
2005-02-28 |
2013-06-05 |
가부시키가이샤 메이지 |
히드로퀴논 장쇄 유도체 및／또는 페녹시 장쇄 유도체 및 이들을 함유하는 의약
|
|
CA2605275C
(en)
|
2005-04-22 |
2015-06-30 |
Barrie Tan |
Use of vitamin e tocotrienols for the inhibition of intracellularly obligate pathogen chlamydia
|
|
ES2714900T3
(es)
|
2005-06-01 |
2019-05-30 |
Bioelectron Tech Corp |
Productos terapéuticos redox activos para el tratamiento de enfermedades mitocondriales y otras afecciones y modulación de biomarcadores energéticos
|
|
WO2007004713A1
(ja)
|
2005-06-30 |
2007-01-11 |
Kyowa Chemical Industry Co., Ltd. |
銀含有アルミニウム硫酸塩水酸化物粒子よりなる抗菌剤およびその利用
|
|
WO2007035496A1
(en)
|
2005-09-15 |
2007-03-29 |
Edison Pharmaceuticals, Inc. |
Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
|
|
WO2007037849A2
(en)
|
2005-09-16 |
2007-04-05 |
Allergan, Inc. |
Compositions and methods for the intraocular transport of therapeutic agents
|
|
AU2006339607A1
(en)
*
|
2005-12-02 |
2007-09-13 |
Sirtris Pharmaceuticals, Inc. |
Modulators of Cdc2-like kinases (Clks) and methods of use thereof
|
|
US20070208086A1
(en)
|
2006-02-15 |
2007-09-06 |
The Regents Of The University Of California |
Ubiquinone analogs and methods of use
|
|
WO2007100652A2
(en)
|
2006-02-22 |
2007-09-07 |
Edison Pharmaceuticals, Inc. |
Side chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
|
|
JPWO2007116750A1
(ja)
|
2006-03-30 |
2009-08-20 |
出光興産株式会社 |
有機エレクトロルミネッセンス素子用材料、及びこれを用いた有機エレクトロルミネッセンス素子
|
|
WO2008108825A2
(en)
|
2006-10-10 |
2008-09-12 |
Burnham Institute For Medical Research |
Neuroprotective compositions and methods
|
|
EP2101808A4
(en)
|
2007-01-10 |
2011-11-30 |
Edison Pharmaceuticals Inc |
TREATMENT OF BREATHLY TROUBLES USING COMPOUNDS OF ERYTHROPOIETIN OR THROMBOPOIETIN ACTIVITY
|
|
EP3539560A1
(en)
|
2007-02-22 |
2019-09-18 |
Children's Hospital & Research Center at Oakland |
Fatty acid formulations and methods of use thereof
|
|
EP2155888B1
(en)
|
2007-05-24 |
2014-07-09 |
Loders Croklaan B.V. |
Process for producing compositions comprising tocopherols and tocotrienols
|
|
WO2008157747A1
(en)
|
2007-06-21 |
2008-12-24 |
The Jackson Laboratory |
Use of inhibition of exonuclease 1 in methods for therapy and diagnostic of neurodegenerative diseases, eye diseases, and mitochondrial disorders
|
|
US8075909B2
(en)
|
2007-09-04 |
2011-12-13 |
University Of Florida Research Foundation, Incorporated |
Contact lens based bioactive agent delivery system
|
|
SI3456707T1
(sl)
|
2007-11-06 |
2020-10-30 |
Ptc Therapeutics, Inc. |
Derivati 4-(P-kuinonil)-2-hidroksibutanamida za zdravljenje mitohondrijske bolezni
|
|
EP2242506A4
(en)
|
2008-01-07 |
2011-12-28 |
Janssen Biotech Inc |
METHOD FOR THE TREATMENT OF ERYTHROPOIETIN HYPORESPONSE ANIMALS
|
|
WO2009089224A1
(en)
|
2008-01-08 |
2009-07-16 |
Edison Pharmaceuticals, Inc. |
(HET) ARYL-p-QUINONE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES
|
|
WO2009111543A2
(en)
|
2008-03-05 |
2009-09-11 |
Edison Pharmaceuticals, Inc. |
Treatment of hearing and balance impairments with redox-active therapeutics
|
|
JP5710277B2
(ja)
*
|
2008-03-05 |
2015-04-30 |
エジソン ファーマシューティカルズ， インコーポレイテッド |
酸化ストレス疾患の処置のための２−置換−ｐ−キノン誘導体
|
|
WO2009140382A2
(en)
|
2008-05-15 |
2009-11-19 |
Edison Pharmaceuticals, Inc. |
Treatment of hearing and balance impairments using compounds having erythropoietin activity
|
|
EP2303309A2
(en)
|
2008-05-22 |
2011-04-06 |
Edison Pharmaceuticals, Inc. |
Treatment of mitochondrial diseases with an erythropoietin mimetic
|
|
JP5798481B2
(ja)
|
2008-06-25 |
2015-10-21 |
エジソン ファーマシューティカルズ， インコーポレイテッド |
酸化ストレス疾患を治療するための２−ヘテロシクリルアミノアルキル−（ｐ−キノン）誘導体
|
|
WO2010005989A1
(en)
|
2008-07-09 |
2010-01-14 |
Edison Pharmaceuticals, Inc. |
Dermatological compositions with anti-aging and skin even-toning properties
|
|
US20100029784A1
(en)
|
2008-07-30 |
2010-02-04 |
Hinman Andrew W |
Naphthoquinone compositions with anti-aging, anti-inflammatory and skin even-toning properties
|
|
WO2010014758A1
(en)
|
2008-07-30 |
2010-02-04 |
Edison Pharmaceuticals, Inc. |
Use of hydrogenated pyrido[4,3-b] indoles for the treatment of oxidative stress
|
|
JP2012502064A
(ja)
*
|
2008-09-10 |
2012-01-26 |
エジソン ファーマシューティカルズ， インコーポレイテッド |
酸化還元活性治療剤を用いての広汎性発達障害の処置
|
|
AU2009302167B9
(en)
|
2008-10-09 |
2014-05-29 |
Ramscor, Inc. |
Composition and method for treating dry eye syndrome
|
|
WO2010045220A1
(en)
|
2008-10-14 |
2010-04-22 |
Edison Pharmaceuticals, Inc. |
Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells
|
|
MY157119A
(en)
|
2008-10-28 |
2016-05-13 |
Edison Pharmaceuticals Inc |
Process for the production of alpha-tocotrienol and derivatives
|
|
HUE037574T2
(hu)
|
2009-04-28 |
2018-09-28 |
Bioelectron Tech Corp |
Leber-féle örökletes optikus neuropátia és domináns optikus atrofia kezelése tokotrienol kinonokkal
|
|
US20100273892A1
(en)
|
2009-04-28 |
2010-10-28 |
Miller Guy M |
Formulations of tocotrienol quinones for the treatment of ophthalmic diseases
|
|
JP2012525398A
(ja)
|
2009-04-28 |
2012-10-22 |
アンペア ライフ サイエンシーズ，インコーポレイテッド |
眼科障害を治療するためのトコトリエノールの局所、眼周囲または眼内使用
|
|
EP2609921A1
(en)
|
2009-06-25 |
2013-07-03 |
Ampere Life Sciences, Inc. |
Treatment of pervasive developmental disorders with tocotrienols or tocotrienol enriched extracts
|
|
US9176146B2
(en)
|
2009-08-03 |
2015-11-03 |
Theta Biomedical Consulting & Development Co., Inc. |
Methods of treating autism spectrum disorders and compositions for same
|
|
US9050275B2
(en)
|
2009-08-03 |
2015-06-09 |
Theta Biomedical Consulting & Development Co., Inc. |
Methods of screening for and treating autism spectrum disorders and compositions for same
|
|
CA2772294C
(en)
|
2009-08-26 |
2018-08-21 |
Guy M. Miller |
Methods for the prevention and treatment of cerebral ischemia
|
|
WO2011041452A2
(en)
|
2009-10-01 |
2011-04-07 |
Ampere Life Sciences, Inc. |
Mouse model for identifying compounds for the treatment of oxidative stress
|
|
CA2797644A1
(en)
|
2009-12-31 |
2011-07-07 |
Edison Pharmaceuticals, Inc. |
Treatment of leigh syndrome and leigh-like syndrome with tocotrienol quinones
|
|
CN102884037A
(zh)
|
2010-03-09 |
2013-01-16 |
爱迪生制药有限公司 |
α-生育醌衍生物的合成，及其使用方法
|
|
WO2011113018A1
(en)
|
2010-03-12 |
2011-09-15 |
Ampere Life Sciences, Inc. |
Measurement and control of biological time
|
|
WO2011126998A1
(en)
|
2010-04-06 |
2011-10-13 |
Edison Pharmaceuticals, Inc. |
Treatment of ataxia telangiectasia
|
|
CA2797581A1
(en)
|
2010-04-27 |
2011-11-03 |
Edison Pharmaceuticals, Inc. |
Formulations of quinones for the treatment of ophthalmic diseases
|
|
WO2012009271A1
(en)
|
2010-07-14 |
2012-01-19 |
Penwest Pharmaceuticals Co. |
Methods of providing anticoagulation effects in subjects
|
|
WO2012019032A1
(en)
|
2010-08-06 |
2012-02-09 |
Ampere Life Sciences, Inc. |
Treatment of mitochondrial diseases with vitamin k
|
|
EA201300215A1
(ru)
|
2010-08-06 |
2013-07-30 |
Эдисон Фармасьютикалз, Инк. |
Лечение митохондриальных болезней нафтохинонами
|
|
US20120295985A1
(en)
|
2010-11-19 |
2012-11-22 |
Miller Guy M |
Methods for improving blood glucose control
|
|
WO2012154613A1
(en)
|
2011-05-06 |
2012-11-15 |
Edison Pharmaceuticals, Inc. |
Improved process for the preparation of d-alpha-tocotrienol from natural extracts
|
|
WO2012170773A1
(en)
|
2011-06-08 |
2012-12-13 |
Edison Pharmaceuticals, Inc. |
Adjunctive therapy for the treatment of mitochondrial disorders with quinones and naphthoquinones
|
|
WO2012174286A1
(en)
|
2011-06-14 |
2012-12-20 |
Edison Pharmaceuticals, Inc. |
Catechol derivatives for treatment of oxidative stress diseases
|
|
ES2795798T3
(es)
|
2011-07-06 |
2020-11-24 |
Ptc Therapeutics Inc |
Tratamiento de aciduria metilmalónica, aciduria isovalérica, y otras acidurias orgánicas con tocotrienol quinonas
|
|
WO2013006736A1
(en)
|
2011-07-06 |
2013-01-10 |
Edison Pharmaceuticals, Inc |
Treatment of leigh syndrome and leigh-like syndrome, including complications of sucla2 mutations, with tocotrienol quinones
|
|
JP2014520894A
(ja)
|
2011-07-19 |
2014-08-25 |
エジソン ファーマシューティカルズ， インコーポレイテッド |
非アルファトコトリエノールの存在下でのアルファトコトリエノールの選択的酸化のための方法
|
|
CA2883882A1
(en)
|
2012-09-07 |
2014-03-13 |
Edison Pharmaceuticals, Inc. |
Benzoquinone derivatives for treating oxidative stress disorders
|
|
CA2902506C
(en)
|
2013-03-08 |
2024-11-19 |
Unilever Global Ip Limited |
Resorcinol compounds for dermatological use
|
|
US20140275045A1
(en)
|
2013-03-15 |
2014-09-18 |
Edison Pharmaceuticals, Inc. |
Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
|
|
US9868711B2
(en)
|
2013-03-15 |
2018-01-16 |
Bioelectron Technology Corporation |
Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
|
|
US9670170B2
(en)
|
2013-03-15 |
2017-06-06 |
Bioelectron Technology Corporation |
Resorufin derivatives for treatment of oxidative stress disorders
|
|
CA2906145A1
(en)
|
2013-03-15 |
2014-09-18 |
Edison Pharmaceuticals, Inc. |
Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disorders
|
|
US9296712B2
(en)
|
2013-03-15 |
2016-03-29 |
Edison Pharmaceuticals, Inc. |
Resorufin derivatives for treatment of oxidative stress disorders
|
|
CA2912871A1
(en)
|
2013-05-31 |
2014-12-04 |
Edison Pharmaceuticals, Inc. |
Carboxylic acid derivatives for treatment of oxidative stress disorders
|
|
EP3389646A1
(en)
|
2015-12-17 |
2018-10-24 |
BioElectron Technology Corporation |
Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
|
|
US20190241497A1
(en)
|
2016-10-28 |
2019-08-08 |
Andrew W. Hinman |
Methods for analyzing p-hydroquinone levels and ratios
|